| Delynn M Williams, MD | |
|
120 W Mckenzie Rd, Suite F, Greenfield, IN 46140-1072 | |
| (317) 468-6200 | |
| (317) 468-6201 |
| Full Name | Delynn M Williams |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 24 Years |
| Location | 120 W Mckenzie Rd, Greenfield, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619915576 | NPI | - | NPPES |
| 200832750 | Medicaid | IN | |
| 200459330A | Other | MEDICAID GROUP#/LOCATION | |
| 000000660690 | Other | IN | ANTHEM |
| 205110 | Other | MEDICARE GRP# |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 01057144 (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Physician Network, Llc | 8325952633 | 107 |
News Archive
Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies...
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.
Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.
› Verified 5 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies...
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.
Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Delynn M Williams, MD Po Box 129, Greenfield, IN 46140-0129 Ph: (317) 468-6270 | Delynn M Williams, MD 120 W Mckenzie Rd, Suite F, Greenfield, IN 46140-1072 Ph: (317) 468-6200 |
News Archive
Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies...
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.
Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.
› Verified 5 days ago
Benjamin Ethan Mcallister, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 W Mckenzie Rd Ste F, Greenfield, IN 46140 Phone: 317-468-6200 Fax: 317-468-6201 | |
John D Chase, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave, Suite 100, Greenfield, IN 46140 Phone: 317-462-5252 Fax: 317-462-8010 | |
Melinda A. Cobb, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 W Mckenzie Rd, Suite F, Greenfield, IN 46140 Phone: 317-468-6200 Fax: 317-468-6201 | |
Heather Renee Downhour, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 145 Green Meadows Drive, Suite 1, Greenfield, IN 46140 Phone: 317-462-1481 | |
Dr. Stanley Joseph Szwast, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 801 N State St, Greenfield, IN 46140 Phone: 317-845-9233 |